Actos Lawsuit News: Judge Overseeing Actos Bladder Cancer Trial in Nevada Considering Sanctions against Takeda Attorneys, Bernstein Liebhard LLP Reports

The Firm is investigating Actos lawsuits on behalf of individuals who allegedly developed bladder cancer after using Actos for a year or more.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Free Case Review
Our Firm is representing a number of .Actos lawsuit clients who allegedly suffered injuries similar to those at issue in this trial. We are monitoring this matter very closely.

New York, NY (PRWEB) April 28, 2014

The state court judge overseeing an Actos lawsuit (http://www.theactoslawsuitcenter.com/) trial in Nevada is considering levying sanctions against attorneys representing Takeda Pharmaceuticals, the manufacturer of the Type 2 diabetes drug, Bernstein Liebhard LLP reports. According to court documents, during a hearing on April 24th, an attorney representing one of the Plaintiffs urged Nevada Circuit Court Judge Kerry Earley to punish the lawyers for violating court orders and displaying allegedly disrespectful behavior during the trial. The Las Vegas Review Journal reported on April 27th that Judge Early had previously warned the defense team for behavior she termed as being “absolutely very egregious.”* (Case Nos. A-13-680556, A-13-680922)

“Our Firm is representing a number of Actos lawsuit clients who allegedly suffered injuries similar to those at issue in this trial. We are monitoring this matter very closely,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to individuals who were treated with Actos for a year or more, and who allegedly went on to develop bladder cancer due to their use of the drug.

Actos Bladder Cancer Lawsuits
According to court documents, lawsuits involving Actos and bladder cancer began to mount shortly after the U.S. Food & Drug Administration (FDA) warned in June 2011 that extended use of the drug could increase the risk that a patient will develop bladder cancer. Court documents indicate that more than 3,000 Actos bladder cancer claims are now pending in courts throughout the country. The Nevada trial involves two individual cases filed by Las Vegas women who allegedly developed bladder cancer after using the medication for more than one year. The women are seeking a multi-billion verdict, which according to court filings, would be the largest ever awarded in Nevada.

Court records indicate that the majority of Actos lawsuits are pending in a federal multidistrict litigation underway in U.S. District Court, Eastern District of Louisiana. On April 7, 2014, its first trial concluded when the jury returned a multi-billion verdict favoring the plaintiff that included $9 billion in punitive damages. (Allen v. Takeda Pharmaceuticals North America Inc., 12-cv-00064)

Alleged victims of Actos and bladder cancer may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. To learn more about filing an Actos bladder cancer lawsuit, please visit Bernstein Liebhard LLP’s website. For additional information, please call 800-511-5092 today.

*reviewjournal.com/news/las-vegas/las-vegas-judge-may-punish-misconduct-actos-trial, Las Vegas Review Journal, April 27, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorney fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.theactoslawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author